← Back to patent-cliff list
Solnatide
Tier C — Watch / tradeSolnatide
Vrije Universiteit Brussel
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：ENaC
Indications (approved)：Acute respiratory distress syndrome, Acute lung injury
Regional status
US
-
EU
Phase II
2012-07-01
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Solnatide?
Approved indications include: Acute respiratory distress syndrome, Acute lung injury.
When does the Solnatide patent expire?
No public expiry year is available for Solnatide yet; this page updates once verified.
How do I get a quote for Solnatide intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-18